Empowering
Regenerative
Medicine
Through MenSC
At Luna Neurogen, we are exploring the groundbreaking potential of MenSCs in stroke recovery and revolutionizing our approach to longevity.
Unlock the Power of Your Own Biology
Discover how a simple, natural resource can be transformed into a powerful therapeutic tool for neurological conditions.
The Luna Advantage
MenSCs represent a revolutionary advancement in regenerative medicine. These adult stem cells offer unique advantages:
  • Non-invasive collection
    from a naturally recurring biological process
  • Ethically sourced
    without controversy
  • Abundant supply
    with regular collection opportunities
  • High proliferation capacity
    compared to other adult stem cells
  • Multipotent differentiation
    potential with neurological applications
  • Powerful regenerative properties
    including neuroprotection, angiogenesis, and immunomodulation
Join Our Journey
Connect with us to learn about opportunities to support our groundbreaking work.
Meet the Team
Our interdisciplinary team brings together expertise in stem cell biology, neuroscience, and clinical medicine to drive our mission forward.
Our Development Pipeline
Our MenSC platform targets the recovery phase, where current options are most limited but regenerative potential is highest.
Phase 1: Foundation & Collection
MenSC Collection Protocol: Developed standardized, non-invasive collection methods
MenSC Isolation & Expansion: Established protocols for efficient isolation and expansion of MenSCs
Phase 2: Characterization & Banking
MenSC Characterization: Comprehensive phenotypic and functional profiling
Cryopreservation Protocol: Optimized methods for long-term preservation
Banking System Establishment: Creating infrastructure for reliable storage and retrieval
Phase 3: Mechanism Studies
Neuronal Protection Models: Investigating MenSCs' ability to prevent neuronal death
Angiogenesis Assessment: Evaluating capacity to promote new blood vessel formation
Immunomodulation Analysis: Studying anti-inflammatory and immune-regulating properties
Phase 4: Therapeutic Development
Stroke Model Development: Creating reliable preclinical models
Therapeutic Efficacy Assessment: Comprehensive testing of MenSC therapies
Safety Studies: Rigorous evaluation of short and long-term safety profiles
40-723-272-088
Email:
andra@luna-neurogen.bio